Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311776 Novel sEH Inhibitors and their Use
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311772 Method and compounds for inhibition of cell death
12/09/2010US20100311769 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
12/09/2010US20100311756 Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311752 Substituted pyridazine derivatives
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311738 Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311708 Use of nor-bile acids in the treatment of arteriosclerosis
12/09/2010US20100311703 New compounds as adenosine a1 receptor antagonists
12/09/2010US20100311679 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
12/09/2010US20100311673 Sulfanyl-tetrahydropyran-based compounds and methods of their use
12/09/2010US20100311662 Treatment of Acute Coronary Syndrome with an Exendin
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311660 Natriuretic peptide receptor-c agonists
12/09/2010US20100311654 Modified Polysaccharide-Based Delivery of Nucleic Acids
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100310678 Compositions and Methods for Nutrition Supplementation
12/09/2010US20100310677 Stable amorphous calcium carbonate comprising phosphorylated amino acids
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension
12/09/2010US20100310634 Transdermal therapeutic system having urea components
12/09/2010US20100310627 Xenotransplant for Stroke Therapy
12/09/2010US20100310607 Pharmaceutical formulations
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310561 Natriuretic fusion proteins
12/09/2010US20100310543 Method of preventing and treating acute brain pathologies
12/09/2010US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
12/09/2010US20100310537 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310535 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310532 Gene targets in anti-aging therapy and tissue repair
12/09/2010US20100310531 Peptide-coated cell localization to diseased or damaged tissues and methods related thereto
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310527 Liposome mediated delivery of lineage determining factors
12/09/2010US20100310521 Polynucleotide sequence for the inhibition of phospholamban synthesis
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310493 Acetamide derivatives as glucokinase activators, their process and medicinal application
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010CA2764480A1 Therapeutic and diagnostic molecules
12/09/2010CA2764449A1 Nucleic acid modulators of glycoprotein vi
12/09/2010CA2764159A1 Active metabolite of a thrombin receptor antagonist
12/09/2010CA2764043A1 Improved method for synthesizing pirfenidone
12/09/2010CA2763838A1 Immunologic tests and kits
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258697A1 Hydroxyquinoxalinecarboxamide derivative
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258447A2 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
12/08/2010EP2258415A2 Medical devices containing rapamycin analogs
12/08/2010EP2258379A1 Use of platelet rich plasma composition
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258364A1 Preventive and/or remedy for vascular diseases
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2257641A1 Farp2 and stk25 and uses thereof
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257303A1 Uses of modified elr-cxc chemokine g31p
12/08/2010EP2257302A2 Extracts of sclerocarya birrea
12/08/2010EP2257296A1 Poly aromatic sodium channel blockers
12/08/2010EP2257274A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
12/08/2010EP2257173A1 Methods of treating cardiovascular disorders associated with atherosclerosis
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010EP1641803B3 Thienopyrimidine derivatives as potassium channel inhibitors
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1276878B1 Reversible immortalization
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010CN201664142U Moxa good-smelling pillow for cerebral-heart comfort
12/08/2010CN1981739B Esmolol preparation
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1965849B Composition extracted from Chinese medicinals for treating coronary heart disease and method for preparing ingredients thereof
12/08/2010CN1939506B Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN1788753B General glycoside extract from tree peony root bark and its preparation method and uses thereof
12/08/2010CN1594355B Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 1595